La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « selective »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
selection < selective < selectively  Facettes :

List of bibliographic references indexed by selective

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]
Ident.Authors (with country if any)Title
000933 (2014) Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
000A37 (2014) Plamena R. Angelova [Canada] ; Bikram Keshari Agrawalla ; Pia A. Elustondo ; Jacob Gordon ; Toshikazu Shiba ; Andrey Y. Abramov ; Young-Tae Chang ; Evgeny V. PavlovIn situ investigation of mammalian inorganic polyphosphate localization using novel selective fluorescent probes JC-D7 and JC-D8.
000B60 (2014) Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada]AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys.
001133 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas StefanisSelective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
001134 (2012) Donald E. Spratt ; Kenneth Wu ; Jordan Kovacev ; Zhen-Qiang Pan ; Gary S. ShawSelective Recruitment of an E2∼Ubiquitin Complex by an E3 Ubiquitin Ligase*
001135 (2012) Elizabeth A. Oberg ; Shanna K. Nifoussi ; Anne-Claude Gingras [Canada] ; Stefan StrackSelective Proteasomal Degradation of the B′β Subunit of Protein Phosphatase 2A by the E3 Ubiquitin Ligase Adaptor Kelch-like 15*
001496 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi [Grèce] ; Pothitos M. Pitychoutis [Grèce] ; Zoi Papadopoulou-Daifoti [Grèce] ; Celine Perier [Espagne] ; Miquel Vila [Espagne] ; Matina Maniati [Grèce] ; Ayse Ulusoy [Suède] ; Deniz Kirik [Suède] ; David S. Park [Canada] ; Keiji Wada [Japon] ; Leonidas Stefanis [Grèce]Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
001723 (2011) Philippe Huot [Canada] ; Susan H. Fox ; Adrian Newman-Tancredi ; Jonathan M. BrotchieAnatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?
001730 (2011) Mustafa Kamani ; Murugesapillai Mylvaganam ; Robert Tian ; Brigitte Rigat [Canada] ; Beth Binnington ; Clifford Lingwood [Canada]Adamantyl Glycosphingolipids Provide a New Approach to the Selective Regulation of Cellular Glycosphingolipid Metabolism*
001778 (2011) James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
001956 (2011) Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada]Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects
001996 (2010) Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. BrotchieReduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001C85 (2010) Robert A. Hodgson [États-Unis] ; Paul J. Bedard [Canada] ; Geoffrey B. Varty [États-Unis] ; Tatiana M. Kazdoba [États-Unis] ; Therese Di Paolo [Canada] ; Michael E. Grzelak [États-Unis] ; Annamarie J. Pond [États-Unis] ; Abdallah Hadjtahar [Canada] ; Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; Aurelie Dare [Canada] ; Bernard R. Neustadt [États-Unis] ; Andrew W. Stamford [États-Unis] ; John C. Hunter [États-Unis]Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
001E92 (2009) Andrew S. Lim [Canada, États-Unis] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Jonathan O. Dostrovsky [Canada] ; William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Richard A. Wennberg [Canada] ; Brian J. Murray [Canada]Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons
002291 (2008) Roxanne Kieltyka ; Johans Fakhoury ; Nicolas Moitessier ; Hanadi Sleiman [Canada]Platinum Phenanthroimidazole Complexes as G‐Quadruplex DNA Selective Binders
002799 (2006) Maryvonne Le Saux [Canada] ; Erika Estrada-Camarena [Canada] ; Thérèse Di Paolo [Canada]Selective estrogen receptor‐α but not ‐β agonist treatment modulates brain α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors
002805 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
002946 (2006) Fernanda G. De Souza [Brésil] ; Mayra D. B. Rodrigues [Brésil] ; Sergio Tufik [Brésil] ; José N. Nobrega [Canada] ; Vania D'Almeida [Brésil]Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats
002A09 (2005) K. Adam Baker [Canada] ; Ivar Mendez [Canada]Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain
002A60 (2005) Jean-Claude Tardif [Canada] ; Ian Ford [Royaume-Uni] ; Michal Tendera [Pologne] ; Martial G. Bourassa [Canada] ; Kim Fox [Royaume-Uni]Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
002B88 (2004) Abdallah Hadj Tahar [Canada] ; Laurent Grégoire ; Aurélie Darré ; Nancy Bélanger ; Leonard Meltzer ; Paul J. BédardEffect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "selective" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "selective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    selective
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022